Mesa Laboratories, Inc.
MLAB

$717.38 M
Marketcap
$132.08
Share price
Country
$0.68
Change (1 day)
$141.17
Year High
$83.68
Year Low

Mesa Laboratories, Inc. develops, manufactures, and sells life sciences tools and quality control products and services in the United States, Europe, the Asia Pacific, and internationally. The company's Sterilization and Disinfection Control segment manufactures and sells biological, cleaning, and chemical indicators that are used to assess the effectiveness of sterilization and disinfection processes in the hospital, dental, medical device, and pharmaceutical industries. This segment also provides testing and laboratory services primarily to the dental industry. Its Biopharmaceutical Development segment develops, manufactures, and sells automated systems for protein analysis (immunoassays) and peptide synthesis solutions. This segment's solutions include protein analysis comprising analysis equipment, CDs, kits, and buffers; and peptide synthesizers that enables to automate chemically synthesized peptides that are used in the creation of peptide therapies, biomaterials, cosmetics, and general research. The company's Calibration Solutions segment designs, manufactures, and markets quality control and calibration products to measure or calibrate temperature, pressure, pH, humidity, and other such parameters used for health and safety purposes in the hospital, medical device manufacturing, pharmaceutical manufacturing, and various laboratory and healthcare environments. This segment's products include continuous monitoring systems, dialysate meters and consumables, data loggers, gas flow calibration and air sampling equipment, and torque testing systems. Its Clinical Genomics segment develops, manufactures, and sells genetic analysis tools that include MassARRAY system and consumables, including chips, panels, and chemical reagent solutions used by clinical labs to perform genomic clinical testing in several therapeutic areas, such as newborn screenings, pharmacogenetics, and oncology. The company was incorporated in 1982 and is headquartered in Lakewood, Colorado.

marketcap

P/E ratio for Mesa Laboratories, Inc. (MLAB)

P/E ratio as of 2024: -2.37

According to Mesa Laboratories, Inc.'s latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is -2.37. At the end of 2023 the company had a P/E ratio of 999.72.

P/E ratio history for Mesa Laboratories, Inc. from 1988 to 2024

PE ratio at the end of each year

Year P/E ratio
2024 -2.37
2023 999.72
2022 710.01
2021 370.01
2020 703.91
2019 117.41
2018 -187.90
2017 40.37
2016 31.10
2015 26.53
2014 34.55
2013 20.60
2012 20.46
2011 15.05
2010 17.39
2009 10.62
2008 15.07
2007 15.15
2006 15.04
2005 18.20
2004 13.70
2003 9.33
2002 12.75
2001 10.08
2000 7.82
1999 9.85
1998 11.91
1997 13.14
1996 19.30
1995 9.07
1994 13.04
1993 12.52
1992 16.10
1991 11.25
1990 6.25
1989 9.38
1988 0.00